Figure 11. Comparison of immunophenoscore (IPS) between high and low risk groups under different immune checkpoint states. In the case of both CTLA4 and PD-1 double-positive (A) or double-negative (B), or PD-1 positive but CTLA4 negative (C), the low-risk group had higher IPS. (D) The high-risk group with CTLA4 positive but PD-1 negative had higher IPS. (E) The expression level of CTLA4 in different risk groups. (F) The risk scores under different immune subtypes.